Expertise in
9
conditions

Patrizia Bonadonna

Verona, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
9
conditions
Verona, IT 

Overview

Patrizia Bonadonna practices practicing medicine in Verona, Italy.

Ms. Bonadonna is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Anaphylaxis, and Hereditary Alpha-Tryptasemia.

She is actively involved in clinical research, co-authoring 146 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Verona, Italy
Other Locations
Vicenza, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
Enrollment Status: Recruiting
Publish Date: May 22, 2026
Intervention Type: Drug
Study Drug: BLU-263
Study Phase: Phase 2/Phase 3
A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy
A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy
Enrollment Status: Active_not_recruiting
Publish Date: September 23, 2025
Intervention Type: Drug
Study Drug: Avapritinib
Study Phase: Phase 2
View 1 Less Clinical Trial

146 Total Publications

Safety of Venom Immunotherapy in Pregnancy: A Multicentre Study.
Safety of Venom Immunotherapy in Pregnancy: A Multicentre Study.
Journal: Allergy
Published: February 24, 2026

Frequently Asked Questions about Patrizia Bonadonna

Is Patrizia Bonadonna a top-rated expert for Mast Cell Activation Syndrome (MCAS)?

MediFind is an objective health platform that identifies experts based on real-world data. Patrizia Bonadonna is classified as an Elite expert for Mast Cell Activation Syndrome (MCAS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Patrizia Bonadonna participate in research or clinical trials?

Yes. Patrizia Bonadonna has published 146 articles and abstracts on conditions like Mast Cell Activation Syndrome (MCAS). You can view a list of Patrizia Bonadonna's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bonadonna's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile